Cadence Bank Has $1.63 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cadence Bank raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,794 shares of the healthcare conglomerate’s stock after buying an additional 46 shares during the quarter. Cadence Bank’s holdings in UnitedHealth Group were worth $1,634,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in UNH. Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth approximately $2,905,000. Asset Planning Services Inc. LA ADV increased its stake in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after purchasing an additional 3,006 shares during the last quarter. Americana Partners LLC raised its stake in shares of UnitedHealth Group by 10.8% during the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after purchasing an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its stake in shares of UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after buying an additional 1,283 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.1 %

Shares of UNH opened at $606.32 on Wednesday. The business’s 50 day simple moving average is $583.53 and its 200-day simple moving average is $554.65. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $557.98 billion, a P/E ratio of 39.50, a PEG ratio of 1.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the company earned $6.56 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on UNH shares. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Barclays dropped their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.